Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
2002; Massachusetts Medical Society; Volume: 346; Issue: 2 Linguagem: Inglês
10.1056/nejmoa011954
ISSN1533-4406
AutoresJoan H. Schiller, David Harrington, Chandra P. Belani, Corey J. Langer, Alan Sandler, James E. Krook, Junming Zhu, David H. Johnson,
Tópico(s)Hepatocellular Carcinoma Treatment and Prognosis
ResumoWe conducted a randomized study to determine whether any of three chemotherapy regimens was superior to cisplatin and paclitaxel in patients with advanced non–small-cell lung cancer.
Referência(s)